Cashu | News | IONS

HomeWatchlistNewsSignalsPicks

DJI

+1.00%

SPX

+0.52%

IXIC

+0.52%

FTSE

+0.72%

N225

+1.43%

AXJO

-0.43%

HomeWatchlistNewsSignalsPicks

Stocks

0.00 (0.00%)

0.000

USD

At close at --,----

Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.

Company

About Us
Careers
Blog
News

Help & Support

Help Center
Contact Us
Pro Support

Legal

Privacy Policy
Terms of Use

Instagram YouTube

© 2024 Cashu PTY LTD.

Join our newsletter to keep up to date with us!

Latest Ionis Pharmaceuticals News

Biogen-Ionis Partnered Drug Shows Benefit In Children With Spinal Muscular Atrophy Previously Treated With Novartis' Zolgensma

Feature Image for interests on Biotech, Briefs, Health Care, Healthcare from benzinga.com

Analyst Expectations For Ionis Pharmaceuticals's Future

Ionis Pharmaceuticals Narrows Q1 Loss, Lifts Revenue Forecast While Drug Sales Surge

Feature Image for interests on Benzinga, Biotech, Briefs, Earnings from benzinga.com

businesswire.com

Ionis to hold fourth quarter and full year 2024 financial results webcast

Feature Image for interests on Healthcare, Stock, Technology from businesswire.com

businesswire.com

GondolaBio and n-Lorem Foundation Partner to Advance Novel ASO Therapies for Genetic Diseases

Feature Image for interests on Healthcare, Stock, Technology from businesswire.com

finance.yahoo.com

Tau Inhibitors Clinical Trial Pipeline Analysis Demonstrates 25+ Key Companies at the Horizon Expected to Transform the Treatment Paradigm, Assesses DelveInsight

Feature Image for interests on Alzheimer’S Disease, Clinical Trial, Financial Services, Healthcare from finance.yahoo.com

finance.yahoo.com

New Higher Dose Nusinersen Efficacy and Safety Data Presented at World Muscle Society Congress, Highlight Potential to Maximize Benefit of Nusinersen in SMA

Feature Image for interests on Biogen, Devote, Dose Regimen, Healthcare from finance.yahoo.com

businesswire.com

n-Lorem Publishes Recommendations for Treating Patients with Heterozygous Toxic Gain of Function Mutations

Feature Image for interests on Healthcare, Stock, Technology from businesswire.com

finance.yahoo.com

Zilganersen granted U.S. FDA Fast Track designation for people living with Alexander disease

Feature Image for interests on Alexander Disease, Designation, Fast Track Designation, Food And Drug Administration from finance.yahoo.com

finance.yahoo.com

Chronic Kidney Disease (CKD) Drugs Market is projected to reach USD 23.8 Billion, garnering a 4.2% CAGR from 2024 to 2034: Transparency Market Research, Inc.

Feature Image for interests on Calcium Channel Blockers, Ckd, Healthcare, Kidney Disease from finance.yahoo.com

Stocks

Health Care

ions

Ionis Pharmaceuticals

IONS

-0.01 (-0.03%)

39.77

USD

At close at Jun 27, 20:41 UTC

Latest Cashu News

Ionis Pharmaceuticals' Partner Biogen Advances SMA Therapy with Promising Phase 1 Results

Ionis Pharmaceuticals: Navigating Mixed Analyst Sentiment in RNA-Targeted Therapies

Ionis Pharmaceuticals: Balancing Innovation and Challenges in RNA-Targeted Therapies